95 related articles for article (PubMed ID: 12569364)
1. A human brain tumor-derived PDGFR-alpha deletion mutant is transforming.
Clarke ID; Dirks PB
Oncogene; 2003 Feb; 22(5):722-33. PubMed ID: 12569364
[TBL] [Abstract][Full Text] [Related]
2. Expression of platelet-derived growth factor (PDGF) in the epididymis and analysis of the epididymal development in PDGF-A, PDGF-B, and PDGF receptor beta deficient mice.
Basciani S; Mariani S; Arizzi M; Brama M; Ricci A; Betsholtz C; Bondjers C; Ricci G; Catizone A; Galdieri M; Spera G; Gnessi L
Biol Reprod; 2004 Jan; 70(1):168-77. PubMed ID: 14522834
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection.
Soroceanu L; Akhavan A; Cobbs CS
Nature; 2008 Sep; 455(7211):391-5. PubMed ID: 18701889
[TBL] [Abstract][Full Text] [Related]
4. Kit and PDGFR-alpha activities are necessary for Notch4/Int3-induced tumorigenesis.
Raafat A; Zoltan-Jones A; Strizzi L; Bargo S; Kimura K; Salomon D; Callahan R
Oncogene; 2007 Feb; 26(5):662-72. PubMed ID: 16878155
[TBL] [Abstract][Full Text] [Related]
5. The role of platelet-derived growth factor signaling in healing myocardial infarcts.
Zymek P; Bujak M; Chatila K; Cieslak A; Thakker G; Entman ML; Frangogiannis NG
J Am Coll Cardiol; 2006 Dec; 48(11):2315-23. PubMed ID: 17161265
[TBL] [Abstract][Full Text] [Related]
6. Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.
Basciani S; Brama M; Mariani S; De Luca G; Arizzi M; Vesci L; Pisano C; Dolci S; Spera G; Gnessi L
Cancer Res; 2005 Mar; 65(5):1897-903. PubMed ID: 15753388
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of PDGF ligands and receptors in the tumor prone ovary of follitropin receptor knockout (FORKO) mouse.
Chen X; Aravindakshan J; Yang Y; Tiwari-Pandey R; Sairam MR
Carcinogenesis; 2006 May; 27(5):903-15. PubMed ID: 16344272
[TBL] [Abstract][Full Text] [Related]
8. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.
Wilczynski SP; Chen YY; Chen W; Howell SB; Shively JE; Alberts DS
Hum Pathol; 2005 Mar; 36(3):242-9. PubMed ID: 15791568
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
[TBL] [Abstract][Full Text] [Related]
10. The alpha PDGFR tyrosine kinase mediates locomotion of two different cell types through chemotaxis and chemokinesis.
Uren A; Yu JC; Gholami NS; Pierce JH; Heidaran MA
Biochem Biophys Res Commun; 1994 Oct; 204(2):628-34. PubMed ID: 7980524
[TBL] [Abstract][Full Text] [Related]
11. Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors.
Rocconi RP; Matthews KS; Kimball KJ; Conner MG; Baker AC; Barnes MN
Reprod Sci; 2008 Sep; 15(7):673-7. PubMed ID: 18492696
[TBL] [Abstract][Full Text] [Related]
12. PDGF-D is a potent transforming and angiogenic growth factor.
Li H; Fredriksson L; Li X; Eriksson U
Oncogene; 2003 Mar; 22(10):1501-10. PubMed ID: 12629513
[TBL] [Abstract][Full Text] [Related]
13. STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma.
Geng L; Shinohara ET; Kim D; Tan J; Osusky K; Shyr Y; Hallahan DE
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):263-71. PubMed ID: 16274936
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of experimental proliferative vitreoretinopathy by inhibiting the platelet-derived growth factor receptor.
Ikuno Y; Leong FL; Kazlauskas A
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3107-16. PubMed ID: 10967071
[TBL] [Abstract][Full Text] [Related]
15. Immunotoxins that target an oncogenic mutant epidermal growth factor receptor expressed in human tumors.
Lorimer IA; Wikstrand CJ; Batra SK; Bigner DD; Pastan I
Clin Cancer Res; 1995 Aug; 1(8):859-64. PubMed ID: 9816055
[TBL] [Abstract][Full Text] [Related]
16. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA
Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019
[TBL] [Abstract][Full Text] [Related]
17. Transformation by oncogenic mutants and ligand-dependent activation of FLT3 wild-type requires the tyrosine residues 589 and 591.
Vempati S; Reindl C; Wolf U; Kern R; Petropoulos K; Naidu VM; Buske C; Hiddemann W; Kohl TM; Spiekermann K
Clin Cancer Res; 2008 Jul; 14(14):4437-45. PubMed ID: 18628457
[TBL] [Abstract][Full Text] [Related]
18. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme.
Joensuu H; Puputti M; Sihto H; Tynninen O; Nupponen NN
J Pathol; 2005 Oct; 207(2):224-31. PubMed ID: 16021678
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived growth factors in the developing avian heart and maturating coronary vasculature.
Van Den Akker NM; Lie-Venema H; Maas S; Eralp I; DeRuiter MC; Poelmann RE; Gittenberger-De Groot AC
Dev Dyn; 2005 Aug; 233(4):1579-88. PubMed ID: 15973731
[TBL] [Abstract][Full Text] [Related]
20. An aberrant autocrine activation of the platelet-derived growth factor alpha-receptor in follicular and papillary thyroid carcinoma cell lines.
Chen KT; Lin JD; Liou MJ; Weng HF; Chang CA; Chan EC
Cancer Lett; 2006 Jan; 231(2):192-205. PubMed ID: 16126335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
